Cytosorbents Corporation (CTSO)
NASDAQ: CTSO
· Real-Time Price · USD
0.98
0.00 (0.00%)
At close: Sep 04, 2025, 1:37 PM
0.00% (1D)
| Bid | 0.69 |
| Market Cap | 61.42M |
| Revenue (ttm) | 33.48M |
| Net Income (ttm) | -9.75M |
| EPS (ttm) | -0.18 |
| PE Ratio (ttm) | -5.44 |
| Forward PE | -7.92 |
| Analyst | Hold |
| Ask | 0.98 |
| Volume | 8,613 |
| Avg. Volume (20D) | 190,327 |
| Open | 0.99 |
| Previous Close | 0.98 |
| Day's Range | 0.97 - 0.99 |
| 52-Week Range | 0.71 - 1.61 |
| Beta | 1.20 |
About CTSO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CTSO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CTSO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Cytosorbents Corporation is scheduled to release its earnings on
Nov 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
-17.23%
Cytosorbents shares are trading lower after the co...
Unlock content with
Pro Subscription
11 months ago
-10%
CytoSorbents shares are trading lower. The company announced it submitted its drugsorb-ATR medical device de novo marketing application to the FDA.
